Application of the DREADD technique in biomedical brain research

Grzegorz Dobrzanski1, Małgorzata Kossut2

  • 1Department of Molecular and Cellular Neurobiology, Nencki Institute of Experimental Biology of Polish Academy of Sciences, Warszawa, Poland.

Summary

Designer Receptors Exclusively Activated by Designer Drugs (DREADD) offers precise control over neural activity. This chemogenetic tool is valuable for brain research and understanding diseases like Parkinson's and addiction.

Related Concept Videos